Cargando…
Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancer
Novel strategies are needed to combat multidrug resistance in pancreatic ductal adenocarcinoma (PDAC). We applied genomic approaches to understand mechanisms of resistance in order to better inform treatment and precision medicine. Altered function of chromatin remodeling complexes contribute to che...
Autores principales: | Wright, Carter A., Gordon, Emily R., Cooper, Sara J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666341/ https://www.ncbi.nlm.nih.gov/pubmed/37996815 http://dx.doi.org/10.1186/s12885-023-11645-0 |
Ejemplares similares
-
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance
por: Gordon, Emily R., et al.
Publicado: (2023) -
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance
por: Gordon, Emily R., et al.
Publicado: (2023) -
Programming and Regulation of Metabolic Homeostasis by HDAC11
por: Sun, Lei, et al.
Publicado: (2018) -
HDAC Regulates Transcription at the Outset of Axolotl Tail Regeneration
por: Voss, S. Randal, et al.
Publicado: (2019) -
Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition
por: Ramaker, Ryne C., et al.
Publicado: (2021)